We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.2B
1-Year Est. Return 38.92%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+38.92%
3 Year Est. Return
+73.78%
5 Year Est. Return
+108.79%
10 Year Est. Return
+308.35%
AUM
$5.23B
AUM Growth
+$525M
Cap. Flow
+$89.6M
Cap. Flow %
1.71%
Top 10 Hldgs %
36.97%
Holding
98
New
9
Increased
41
Reduced
32
Closed
5

Top Buys

Rank Stock Value
1
RCI icon
Rogers Communications
RCI
+$22.8M
2
ADNT icon
Adient
ADNT
+$21.9M
3
OTEX icon
Open Text
OTEX
+$21.4M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$17.6M
5
AMRZ
Amrize Ltd
AMRZ
+$13.8M

Top Sells

Rank Stock Value
1
SKX
Skechers
SKX
+$37.2M
2
TD icon
Toronto Dominion Bank
TD
+$5.02M
3
NTR icon
Nutrien
NTR
+$3.32M
4
IIF
Morgan Stanley India Investment Fund
IIF
+$2.77M
5
HBM icon
Hudbay
HBM
+$2.75M

Sector Composition

Rank Sector Weight
1 Financials 34.05%
2 Communication Services 19.07%
3 Materials 11.57%
4 Healthcare 9.74%
5 Technology 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPRY icon
76
ARS Pharmaceuticals
SPRY
$612M
$431K 0.01%
24,700
– –
SKX
77
DELISTED
Skechers
SKX
$424K 0.01%
6,725
-648,075
-99% -$37.2M
FTS icon
78
Fortis
FTS
$28.7B
$405K 0.01%
8,500
– –
EMA
79
Emera Inc
EMA
$15.6B
$388K 0.01%
+8,485
New +$381K
NXPI icon
80
NXP Semiconductors
NXPI
$60.4B
$388K 0.01%
+1,775
New +$347K
VALE icon
81
Vale
VALE
$62.6B
$356K 0.01%
36,650
– –
MSFT icon
82
Microsoft
MSFT
$3.71T
$317K 0.01%
638
– –
FCX icon
83
Freeport-McMoran
FCX
$97.5B
$300K 0.01%
+6,925
New +$263K
MGTX icon
84
MeiraGTx Holdings
MGTX
$1.21B
$295K 0.01%
45,300
– –
ERO icon
85
Ero Copper
ERO
$3.58B
$244K ﹤0.01%
14,500
– –
MLYS icon
86
Mineralys Therapeutics
MLYS
$2.41B
$223K ﹤0.01%
16,500
– –
NAMS icon
87
NewAmsterdam Pharma
NAMS
$3.34B
$213K ﹤0.01%
+11,775
New +$215K
TCRX icon
88
TScan Therapeutics
TCRX
$52M
$139K ﹤0.01%
95,875
+18,775
+24% +$27.1K
AURA icon
89
Aura Biosciences
AURA
$826M
$133K ﹤0.01%
21,200
– –
ETNB
90
DELISTED
89bio
ETNB
$105K ﹤0.01%
10,700
– –
REPL icon
91
Replimune Group
REPL
$1.01B
$100K ﹤0.01%
+10,800
New +$94.2K
HUMA icon
92
Humacyte
HUMA
$194M
$96K ﹤0.01%
45,950
+21,150
+85% +$40.6K
ALDX icon
93
Aldeyra Therapeutics
ALDX
$93.5M
$66.3K ﹤0.01%
17,300
– –
DUK icon
94
Duke Energy
DUK
$97.3B
– –
-2,050
Closed -$250K
IIF
95
Morgan Stanley India Investment Fund
IIF
$220M
– –
-113,375
Closed -$2.77M
KMB icon
96
Kimberly-Clark
KMB
$36.5B
– –
-1,515
Closed -$215K
PLRX icon
97
Pliant Therapeutics
PLRX
$65M
– –
-10,400
Closed -$14K
PROK icon
98
ProKidney
PROK
$337M
– –
-15,900
Closed -$13.9K
1 2 3
4

Similar funds

NP
NorthRock Partners Minneapolis, Minnesota $6.2B AUM 15.8% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
CA
Cambridge Associates Boston, Massachusetts $6.27B AUM 14.78% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Letko, Brosseau & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Letko, Brosseau & Associates held 98 positions worth $5.23B, up 11% from $4.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Letko, Brosseau & Associates's Q2 2025 filing shows 9 new, 41 increased, 32 reduced and 5 closed positions. Its largest new stake was Adient: 1,481,963 shares worth $28.8M. The largest sale was Skechers, an estimated $37.2M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Communication Services and Materials.

  • Letko, Brosseau & Associates's largest Q2 2025 buy was Adient: 1,481,963 shares worth $28.8M.
  • Letko, Brosseau & Associates added most to Rogers Communications in Q2 2025, an estimated $22.8M increase.
  • Letko, Brosseau & Associates's biggest Q2 2025 reduction was Skechers, cutting an estimated $37.2M.
  • Letko, Brosseau & Associates fully exited Morgan Stanley India Investment Fund in Q2 2025, selling an estimated $2.77M.
  • Letko, Brosseau & Associates's ten largest holdings make up 37% of its $5.23B portfolio in Q2 2025.
  • Letko, Brosseau & Associates opened 9 new positions and closed 5 in Q2 2025.
  • Letko, Brosseau & Associates's portfolio value rose 11% quarter-over-quarter to $5.23B.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2025, filed 8 Aug 2025.